相关实验视频
Updated: Jul 15, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
在急性冠状动脉综合征患者中提卡格勒与普拉苏格勒相比:系统性审查和元分析
Rajendra P Shah1, Aimen Shafiq2, Mohammad Hamza3
1Department of Cardiology, University of Florida/Malcom Randall Veterans Affairs Medical Center, Florida, USA.
普拉苏格勒和提卡格勒在预防急性冠状动脉综合征患者的心肌梗塞方面具有同等的有效性. 这次元分析发现,两种抗血小板疗法之间的死亡率,支架血栓形成,中风或重大出血没有显著差异.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 对于急性冠状动脉综合征 (ACS) 中的普拉苏格勒与提卡格雷勒的比较数据有限.
- 了解这些P2Y12抑制剂的比较疗效和安全性对于最佳的ACS管理至关重要.
结论:
- 普拉苏格勒和提卡格勒在预防急性冠状动脉综合征患者心脏病发作时同样有效.
- 这两种药物在重大出血和血栓事件方面表现出相似的安全性.
更多相关视频
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations